In Brief This Week: Sequenom; Beckman Coulter; Expression Analysis; Crown Bioscience, Horizon Discovery; DiagnoCure; Pall; Pressure BioSciences | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom said in its Form 10-K filed with the US Securities and Exchange Commission this week that the US Patent and Trademark Office on March 12 declared a patent interference between US Patent No. 8,008,018 held by Verinata Health, now part of Illumina, and Sequenom's pending patent application No. 13/070,275. In February 2012, Verinata and Stanford University sued Sequenom alleging it infringes the patent through the offering of its MaterniT21 Plus test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."

Oct
13
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss sample collection challenges associated with tumor sequencing, with a particular focus on somatic variant testing in plasma.